AI-Designed Vaccine Antigen Clears First Human Safety Trial
Researchers at the University of Cambridge and biotech company DIOSynVax reported that an AI-designed coronavirus vaccine antigen was safe and well tolerated in 39 adults, but protection remains unproven.
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Wow
0
Sad
0
Angry
0
Christopher Holloway
Christopher Holloway is the founder and director of Progressive Robot, a UK-based technology company. A full-stack engineer with more than two decades of experience, he works across PHP development, ecommerce, Linux infrastructure, technical SEO and AI automation, and writes here on technology, AI, hardware and software.
Comments (0)